Stay up to date.
Helsana Supplementary Insurance
From September 2022, Helsana Insurance will reimburse the Pregnolia examination via its PRIMEO supplementary insurance.
April 4, 2022
We are very excited to participate in Tech4Eva 2022, the only FemTech start-up accelerator in Switzerland.
9 exciting months await us!
November 30, 2021
From January 2022, CSS Insurance will include the Pregnolia examination in the coverage of its supplementary outpatient insurance.
May 4, 2021
We are excited to announce that Sanitas will now cover the cost of a preventive check-up with Pregnolia for its customers under a supplementary outpatient insurance plan.
The first 2021 edition of Obstetrica, a swiss midwifery journal, features a large article about the increasing importance of cervical stiffness measurements in the context of a possible preterm birth.
November 17, 2020
It is great that this day was created!
Today we celebrate the little fighters who started their lives too early. Unfortunately, prematurity is the second most common reason for child mortality, and the trend is rising (WHO Report, 2012).
Pregnolia was featured again in the Top 100 Swiss Startups ranking
Here is the ranking list.
The Pregnolia System revamps a classical gynaecological assessment, cervical palpation. Cervical stiffness measured with our device is considerably more reliable than digital palpation.
Prof. Kristin Myers is an expert in the field of biomechanics during pregnancy. In this interview, she explains why Columbia University is doing studies with Pregnolia's measurement device.
Dr. Sabrina Badir and her company, based in Schlieren, have developed a sensor to diagnose the risk of premature birth. She is currently fundraising and continuing the efforts to collect further clinical data.
Pregnolia was presented as one of the Best Practises in the Health Report 2020 by Corinna Mühlhausen concerning trends and developments in the healthcare industry.
Prof. Kristin Myers is one of the researchers highlighted by MIT Technology Review for their work on pregnancy related topics. In this profile, she talks about her work at Columbia University and the importance of cervical stiffness to maintain pregnancy, including the usage of the Pregnolia System in her research.
Pregnolia was part of the 24 hours report by NZZaS - 13 unique stories that represent Switzerland.
Dr. Sabrina Badir presented Pregnolia at the Female Innovation Forum 2019 in front of 200 innovators!
Pregnolia was nominated as one of the TOP 100 Swiss Startups.
Pregnolia AG has been awarded an CHF 1.4m SME Instrument Phase 2 grant. This EU Horizon 2020 business innovation grant follows the successful Phase 1 feasibility study and will be invested towards improving the manufacturability of the Pregnolia System. It will allow Pregnolia to streamline the production of its product, increase capacity and facilitate logistics – a fundamental step in company growth.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 873553.
For more information read the latest interview by Dr. Sabrina Badir.
Sifted listed Pregnolia as one of the Europe's coolest femtech companies 2019.
Pregnolia was featured in an article in the Handelszeitung regarding women's health.
Pregnolia was selected as one of the 50 Swiss high-tech startups to invest in by the business magazine Bilan and its jury of experienced entrepreneurs.
Pregnolia has been named the recipient of a SME Instrument Phase 1 grant. This EU Horizon 2020 business innovation grant provides support for close-to-market feasibility assessment activities. Pregnolia will use the funding for further studying the industrialisation and production scalability of the Pregnolia System.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 835715.
Pregnolia was awarded the Innosuisse Certificate. The Certificate is given by the Innosuisse Innovation Council to startups that are ready for sustainable growth. Pregnolia was one of the seven companies to receive Innosuisse Certificate – former CTI Startup Label – in 2018.
Medtech as a research field has become more important at ETH. The biomechanics engineer Dr. Sabrina Badir developed a device that might support the risk assessment of a premature birth.
Dr. Reihl and Dr. Kohler were elected to the Board of Directors. Both have extensive experience in Medtech and Health Management.
The ETH-Spin-off Pregnolia has developed a small device to enable gynecologists to measure the cervical stiffness quantitatively.
Dr. Sabrina Badir and her life-changing invention have been featured in ZEIT ONLINE. The Pregnolia System provides more data on the consistency of the cervix than conventional methods.
The biomechanics Dr. Sabrina Badir wants to bring a device to the market that improves risk assessment for preterm birth. The state of the art and need for advancement, is discussed during the interview «Focus».
Presentation of the device and studies.
Pregnolia was nominated in rank 24 of TOP 100 Swiss Startups.
Pregnolia participates at the Global Pitch Fest during the Venture Leaders Programm in Boston.
With the aspiration technique, Dr. Sabrina Badir wants to improve diagnosis and prevention of preterm birth.
Pregnolia obtained 100‘000 Swiss Francs from W.A. de Vigier Foundation. The ceremony took place in Solothurn.
Watch the Pregnolia Pitch (in german)
ETH researcher have developed a sensor to measure the risk for premature birth in the future.
The probe measures the stiffness of the cervix: The researcher from Zurich wants to improve the assessment of preterm birth with this awardwining idea.
ETH biomechanic Dr. Sabrina Badir impressed the jury at the international ideas competition Falling Walls Lab. She developed a device that can determine the risk of a premature birth.
Pregnolia (Pregnostics) wins the prize for the best business idea.